Literature DB >> 9817896

Critical evaluation of 4-week incubation for fungal cultures: is the fourth week useful?

J A Labarca1, E A Wagar, A E Grasmick, H M Kokkinos, D A Bruckner.   

Abstract

To determine the benefit of a 4-week incubation for mycology cultures, we evaluated all positive cultures during the fourth week of incubation in a 1-year period. Of 3,855 positive mycology cultures (yeast, 82%; molds, 18%), 62 (1.6%) were positive during the fourth week (yeast, 42%; molds, 58%). Only 15 of the 62 cultures (24%) were considered clinically relevant (2 isolates from invasive fungal infection and 13 isolates from cutaneous mycosis). With the exception of those from skin samples, isolates recovered during the fourth week are rarely important for patient care.

Entities:  

Mesh:

Year:  1998        PMID: 9817896      PMCID: PMC105263     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Duration of incubation of fungal cultures.

Authors:  A J Morris; T C Byrne; J F Madden; L B Reller
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

Review 2.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 3.  Epidemiology of nosocomial fungal infections, with emphasis on Candida species.

Authors:  W R Jarvis
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

4.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

  4 in total
  6 in total

Review 1.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

2.  A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.

Authors:  K L Mortensen; H K Johansen; K Fuursted; J D Knudsen; B Gahrn-Hansen; R H Jensen; S J Howard; M C Arendrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-04       Impact factor: 3.267

3.  Clinical benefit of recovering dermatophytes from skin swabs sent for bacterial culture.

Authors:  Gillian Mabbott; Jocelyn Smith; Arthur J Morris
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Thomas F Patterson; George R Thompson; David W Denning; Jay A Fishman; Susan Hadley; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; M Hong Nguyen; Brahm H Segal; William J Steinbach; David A Stevens; Thomas J Walsh; John R Wingard; Jo-Anne H Young; John E Bennett
Journal:  Clin Infect Dis       Date:  2016-06-29       Impact factor: 9.079

5.  Overlapping presentation of fungal tubulointerstitial nephritis in an immunosuppressed pediatric patient.

Authors:  James B Tee; Vivian Reznik; Henry F Krous
Journal:  Pediatr Nephrol       Date:  2009-03-19       Impact factor: 3.714

6.  Recovery and Its Dynamics of Filamentous Fungi from Clinical Specimen Cultures: An Extensive Study.

Authors:  Jian R Bao; Ronald N Master; Robert S Jones; Richard B Clark; Elizabeth C Moore; Kileen L Shier
Journal:  Microbiol Spectr       Date:  2021-08-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.